Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dapagliflozin Promotes Neovascularization by Improving Paracrine Function of Skeletal Muscle Cells in Diabetic Hindlimb Ischemia Mice Through PHD2/HIF-1α Axis
Dyah Ari Nugrahaningrum, Olivia Marcelina, Caiping Liu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 20

Showing 20 citing articles:

SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways
Li Ma, Rongjun Zou, Wanting Shi, et al.
Theranostics (2022) Vol. 12, Iss. 11, pp. 5034-5050
Open Access | Times Cited: 81
Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Vascular Cell Function and Arterial Remodeling
William Durante, Ghazaleh Behnammanesh, Kelly J. Peyton
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8786-8786
Open Access | Times Cited: 85
Therapeutic angiogenesis-based strategy for peripheral artery disease
Jingxuan Han, Lailiu Luo, Olivia Marcelina, et al.
Theranostics (2022) Vol. 12, Iss. 11, pp. 5015-5033
Open Access | Times Cited: 40
Dapagliflozin‐Loaded Exosome Mimetics Facilitate Diabetic Wound Healing by HIF‐1α‐Mediated Enhancement of Angiogenesis
Weiyue Zhang, Lutong Wang, Haoyu Guo, et al.
Advanced Healthcare Materials (2022) Vol. 12, Iss. 7
Open Access | Times Cited: 40
Role and molecular mechanisms of SGLT2 inhibitors in pathological cardiac remodeling (Review)
B K Chen, Jing Guo, Ye Hongmei, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 9
High-strength double-network silk fibroin based hydrogel loaded with Icariin and BMSCs to inhibit osteoclasts and promote osteogenic differentiation to enhance bone repair
Huiling Liu, Yang Jiao, Tymour Forouzanfar, et al.
Biomaterials Advances (2024) Vol. 160, pp. 213856-213856
Closed Access | Times Cited: 8
Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity
Vincenzo Quagliariello, Maria Laura Canale, Isabella Bisceglia, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 8
Gastroprotective effect of dapagliflozin in ethanol-induced gastric lesions in rats: Crosstalk between HMGB1/RAGE/PTX3 and TLR4/MyD88/VEGF/PDGF signaling pathways
Rania M. Salama, Rodaina H Ahmed, Alaa A Farid, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109686-109686
Closed Access | Times Cited: 16
Salidroside facilitates therapeutic angiogenesis in diabetic hindlimb ischemia by inhibiting ferroptosis
Yi‐Cheng Wang, Jingxuan Han, Lailiu Luo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114245-114245
Open Access | Times Cited: 15
SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art
David Aristizábal-Colorado, Martín Ocampo Posada, Wilfredo Antonio Rivera Martínez, et al.
American Journal of Cardiovascular Drugs (2024) Vol. 24, Iss. 6, pp. 707-718
Closed Access | Times Cited: 5
SGLT2 inhibitor Dapagliflozin alleviates cardiac dysfunction and fibrosis after myocardial infarction by activating PXR and promoting angiogenesis
Min Wang, Xiameng Liu, Bo Ding, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116994-116994
Open Access | Times Cited: 4
Dapagliflozin improves endothelial cell dysfunction by regulating mitochondrial production via the SIRT1/PGC-1α pathway in obese mice
Lianqi He, Yanhua Li, Di Zhang, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 615, pp. 123-130
Closed Access | Times Cited: 20
SGLT2 inhibitor empagliflozin promotes revascularization in diabetic mouse hindlimb ischemia by inhibiting ferroptosis
Jingxuan Han, Lailiu Luo, Yi‐Cheng Wang, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 6, pp. 1161-1174
Closed Access | Times Cited: 17
Smartly Engineered Casein Manganese Oxide Nanobiomaterials and Its Potential Therapeutic Angiogenesis Applications for Wound Healing and Limb Ischemia
Shagufta Haque, Rajesh Kotcherlakota, Pranav Bhamidipati, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 9
Closed Access | Times Cited: 9
PER1 promotes functional recovery of mice with hindlimb ischemia by inducing anti-inflammatory macrophage polarization
Ding Yang, Shengyun Wan, Long Ma, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 644, pp. 62-69
Closed Access | Times Cited: 6
Anti-diabetic drug canagliflozin hinders skeletal muscle regeneration in mice
Xinhuang Lv, Xiaoxia Cong, Jinliang Nan, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 10, pp. 2651-2665
Open Access | Times Cited: 8
Sodium-Glucose Cotransporter-2 Inhibitors in Vascular Biology: Cellular and Molecular Mechanisms
Lei Xiao, Xin Nie, Yanyan Cheng, et al.
Cardiovascular Drugs and Therapy (2021) Vol. 35, Iss. 6, pp. 1253-1267
Closed Access | Times Cited: 11
Dapagliflozin promotes angiogenesis in hindlimb ischemia mice by inducing M2 macrophage polarization
Heng Yang, Wanqi Lan, Wu Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Potentially active compounds that improve PAD through angiogenesis: A review
Zibo Liu, Xin-yun Fan, Chen-wei Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115634-115634
Open Access | Times Cited: 2
Current and Novel Emerging Medical Therapies for Peripheral Artery Disease: A Literature Review
AmirAhmad Arabzadeh, Elnaz Faghfuri, Saiedeh Razi Soofiyani, et al.
Advanced Pharmaceutical Bulletin (2022) Vol. 13, Iss. 2, pp. 259-268
Open Access | Times Cited: 2
Page 1

Scroll to top